Pharmaceutical Company OZON
Founded in 2001, ОЗОН Фармацевтика focuses on improving the quality of life for people with various conditions in Russia and the CIS for over a decade. As one of the leading generic drug manufacturers in the domestic pharmaceutical market, OZON Pharmaceutical Company produces analogs of patented drugs. With GMP standards, the company ensures the production of high-quality medications that are accessible to wider population segments.
The company currently produces over 150 million packages annually, with a product portfolio comprising more than 100 generic drug names. Continuously expanding its product range and production volumes, OZON Pharmaceutical Company maintains its commitment to high quality and product accessibility, guided by the principles of innovation, responsibility, speed, teamwork, and ambition shared by all employees.
Committed to achieving ambitious goals, OZON recognizes the importance of continuous learning and employee training. Tailored training programs are designed for each organizational level, with a focus on GMP compliance for production staff and short-term qualification enhancement programs for the administrative staff.
The company's top management undergoes an MBA program, emphasizing the significance of continuous education in attaining the company's objectives.
Industries: Manufacturing, Pharmaceutical
Headquarters: Russia
There is no investment information
No recent news or press coverage available for Фармацевтическая компания ОЗОН.